XML 38 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Option Awards and Restricted Stock Grants

A summary of stock option awards and restricted stock grants for the nine-months ended September 30, 2018 is presented below:

 

    Stock Options   Restricted Stock Awards   Weighted
Average
Equity Awards   Options
Outstanding
 

Weighted

Average

Exercise

Price

  Non-vested
Restricted
Stock
Outstanding
 

Weighted

Average

Grant

Date

Fair Value

  Contractual
Terms of
Equity
Awards
(in years)
                     
Equity awards outstanding at January 1, 2018     703,442     $ 10.34       -     $ -          
                                         
Equity awards granted     2,629,004     $ 2.26       35,000     $ 2.71          
                                         
Vested and issued     -     $ -       (6,000 )   $ 2.64          
                                         
Equity awards forfeited, cancelled or expired     (113,701 )   $ 40.23       -     $ -          
                                         
Equity awards outstanding at September 30, 2018     3,218,745     $ 2.67       29,000     $ 2.72       9.4  
                                         
Aggregate intrinsic value of outstanding equity awards at September 30, 2018   $ 1,384,245             $ 1,700                  
                                         
Equity awards exercisable at September 30, 2018     1,677,998     $ 2.94                       9.3  
                                         
Aggregate intrinsic value of equity awards exercisable at September 30, 2018   $ 706,552                                  

 

Schedule of Assumptions Used to Determine Fair Value of Options Granted

The Company used the following assumptions for determining the fair value of options granted under the Black-Scholes option pricing model:

 

    Nine Months Ended September 30,  
    2018     2017  
Risk-free interest rate     2.82 – 3.02 %     2.21 %
Expected volatility     99.9 -102.1 %     90.4 %
Expected life (in years)     8.0 - 10.0       10.00  
Expected dividend yield     - %     - %